- Home
- YMAB vs HIVE Comparison
YMAB vs HIVE Comparison
Compare YMAB & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- HIVE
- Stock Information
- Founded
- YMAB 2015
- HIVE 1987
- Country
- YMAB United States
- HIVE United States
- Employees
- YMAB N/A
- HIVE N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- HIVE
- Sector
- YMAB Health Care
- HIVE
- Exchange
- YMAB Nasdaq
- HIVE Nasdaq
- Market Cap
- YMAB 386.7M
- HIVE 459.0M
- IPO Year
- YMAB 2018
- HIVE N/A
- Fundamental
- Price
- YMAB $8.61
- HIVE $3.88
- Analyst Decision
- YMAB Buy
- HIVE Strong Buy
- Analyst Count
- YMAB 10
- HIVE 6
- Target Price
- YMAB $13.91
- HIVE $6.83
- AVG Volume (30 Days)
- YMAB 874.6K
- HIVE 28.0M
- Earning Date
- YMAB 11-07-2025
- HIVE 11-12-2025
- Dividend Yield
- YMAB N/A
- HIVE N/A
- EPS Growth
- YMAB N/A
- HIVE 42.43
- EPS
- YMAB N/A
- HIVE 0.34
- Revenue
- YMAB $85,385,000.00
- HIVE $128,649,000.00
- Revenue This Year
- YMAB N/A
- HIVE $190.37
- Revenue Next Year
- YMAB $13.97
- HIVE $41.48
- P/E Ratio
- YMAB N/A
- HIVE $11.32
- Revenue Growth
- YMAB N/A
- HIVE 4.47
- 52 Week Low
- YMAB $3.55
- HIVE $1.26
- 52 Week High
- YMAB $16.11
- HIVE $5.54
- Technical
- Relative Strength Index (RSI)
- YMAB 81.21
- HIVE 79.46
- Support Level
- YMAB $8.50
- HIVE $3.70
- Resistance Level
- YMAB $8.56
- HIVE $4.33
- Average True Range (ATR)
- YMAB 0.02
- HIVE 0.25
- MACD
- YMAB -0.12
- HIVE 0.11
- Stochastic Oscillator
- YMAB 100.00
- HIVE 74.14
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.